gallic acid has been researched along with Liver Dysfunction in 7 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A complex synthesized from GA and soybean lecithin (SL-GAC), significantly improved bioavailability of GA and pharmacological activities." | 1.91 | Amelioration effects of the soybean lecithin-gallic acid complex on iron-overload-induced oxidative stress and liver damage in C57BL/6J mice. ( Cui, W; Dai, W; Fang, F; Gao, Y; Wu, C; Yan, F; Zhang, W, 2023) |
| "Obesity is the leading risk factor for developing metabolic (dysfunction)-associated fatty liver disease (MAFLD)." | 1.72 | Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice. ( Aubourg, SP; Barriga, A; Dovale-Rosabal, G; Espinosa, A; Palomino-Calderón, A; Rodríguez, A; Romero, N; Troncoso, RH, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Dovale-Rosabal, G | 3 |
| Espinosa, A | 3 |
| Rodríguez, A | 3 |
| Barriga, A | 3 |
| Palomino-Calderón, A | 3 |
| Romero, N | 3 |
| Troncoso, RH | 3 |
| Aubourg, SP | 3 |
| Wu, C | 1 |
| Zhang, W | 1 |
| Yan, F | 1 |
| Dai, W | 1 |
| Fang, F | 1 |
| Gao, Y | 1 |
| Cui, W | 1 |
| Taghizadeh, M | 1 |
| Rashidi, AA | 1 |
| Taherian, AA | 1 |
| Vakili, Z | 1 |
| Mehran, M | 1 |
| Shimoda, H | 1 |
| Tanaka, J | 1 |
| Kikuchi, M | 1 |
| Fukuda, T | 1 |
| Ito, H | 1 |
| Hatano, T | 1 |
| Yoshida, T | 1 |
| Anand, KK | 1 |
| Singh, B | 1 |
| Saxena, AK | 1 |
| Chandan, BK | 1 |
| Gupta, VN | 1 |
| Bhardwaj, V | 1 |
| Lu, XY | 1 |
| Chen, WW | 1 |
7 other studies available for gallic acid and Liver Dysfunction
| Article | Year |
|---|---|
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice.
Topics: Animals; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gallic Acid; Glycerides; Liver D | 2022 |
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice.
Topics: Animals; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gallic Acid; Glycerides; Liver D | 2022 |
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice.
Topics: Animals; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gallic Acid; Glycerides; Liver D | 2022 |
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice.
Topics: Animals; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gallic Acid; Glycerides; Liver D | 2022 |
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice.
Topics: Animals; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gallic Acid; Glycerides; Liver D | 2022 |
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice.
Topics: Animals; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gallic Acid; Glycerides; Liver D | 2022 |
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice.
Topics: Animals; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gallic Acid; Glycerides; Liver D | 2022 |
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice.
Topics: Animals; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gallic Acid; Glycerides; Liver D | 2022 |
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice.
Topics: Animals; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Gallic Acid; Glycerides; Liver D | 2022 |
Amelioration effects of the soybean lecithin-gallic acid complex on iron-overload-induced oxidative stress and liver damage in C57BL/6J mice.
Topics: Animals; Antioxidants; Deferoxamine; Gallic Acid; Glycine max; Iron; Iron Overload; Lecithins; Lipid | 2023 |
The Protective Effect of Hydroalcoholic Extract of Rosa canina (Dog Rose) Fruit on Liver Function and Structure in Streptozotocin-Induced Diabetes in Rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Blood Glucose; Diabetes Co | 2018 |
Walnut polyphenols prevent liver damage induced by carbon tetrachloride and d-galactosamine: hepatoprotective hydrolyzable tannins in the kernel pellicles of walnut.
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Flavonoids; | 2008 |
3,4,5-Trihydroxy benzoic acid (gallic acid), the hepatoprotective principle in the fruits of Terminalia belerica-bioassay guided activity.
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Female; Gallic Acid | 1997 |
[Current serodiagnosis of liver diseases. III].
Topics: Clinical Enzyme Tests; Esterases; Gallic Acid; Humans; Liver Diseases; Phosphoric Monoester Hydrolas | 1975 |
[Protective effects of propyl gallate on acute liver injury induced by ethanol in mice and rats].
Topics: Animals; Chemical and Drug Induced Liver Injury; Ethanol; Gallic Acid; Lipid Peroxides; Liver Diseas | 1987 |